Advertisement

The Importance of Tissue Distribution in Pharmacokinetics

  • James R. Gillette

Abstract

In evoking pharmacological and toxicological responses, drugs generally combine either reversibly or irreversibly with action sites on intrastitial macromolecules or organelles, and thereby cause alterations of physico-chemical or biochemical processes in the living animal. These alterations can be evoked by a number of mechanisms. Drugs can either mimic or block the action of normally occurring substances by combining with receptor sites. Drugs can alter the localization of normally occurring substances by interfering with transport mechanisms or changing the number of storage sites. Drugs can change the concentrations of normally occurring substances in tissues by reacting with them directly or by altering the activities of enzymes that catalyze their formation or destruction.

Keywords

Central Compartment Blood Flow Rate Unbind Drug Unbind Concentration Melanin Granule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beierwaltes, W. H., Liebennan, L. M., Vanna, V. M., and Counsell, R. E., 1968, J. Am. Med. Assoc. 206: 97.CrossRefGoogle Scholar
  2. Bernstein, H., Zvaifler, N., Rubin, M, and Mansour, A. M., 1963, Invest. Ophthalmol. 2: 384.PubMedGoogle Scholar
  3. Bogdanski, D. F., Blaszkowski, T. P., and Brodie, B. B., 1971, J. Pharm. Exp. Therap. 179: 372.Google Scholar
  4. Brodie, B. B., Bermsteom, E., and Mark, L. C., 1952, J. Pharmacol. Exp. Therap. 105: 421.Google Scholar
  5. Brodie, B. B., Aronow, L., and Axelrod, J., 1954, J. Pharmacol. Exp. Therap. 111: 21.Google Scholar
  6. Bums, J. J., Rose, R. K., Chenkin, T., Goldman, A., Schillert, A., and Brodie, B. B., 1953, J. Pharmacol. Exp. Therap. 109: 346.Google Scholar
  7. Chignell, C. F. and Starkweather, D. K., 1971a, Molecular Pharmacology 7: 229.PubMedGoogle Scholar
  8. Chignell, C. F., Vesell, E. S., Starkweather, D. K., and Berlin, C. M., 1971b, Clin. Pharm. Therap. 12: 897.PubMedGoogle Scholar
  9. Chignell, C. F., 1972, in: Methods in Pharmacology, Vol. 2, p. 39, Physical Methods (Chignell, C. F., ed.) Appleton-Century-Crofts, New York.Google Scholar
  10. Dingell, J. V., Sulser, F., and Gillette, J. R., 1964, J. Pharmacol. Exp. Therap. 143: 14.Google Scholar
  11. Dollery, C. T., Emslie-Smith, D., and Muggleton, P. F., 1961, Brit. J. Pharmacol. 17: 488.PubMedGoogle Scholar
  12. Gibaldi, M., Nagashima, R., and Levy, G., 1969, J. Pharm. Sci. 58: 193–197.CrossRefGoogle Scholar
  13. Gillette, J. R., 1968, in: Importance of Fundamental Principles in Drug Evaluation, p. 69 (Tedeschi, D. H., and Tedeschi, R. E., eds.) Proceedings of a Symposium Organized by the Section on Pharmacology and Biochemistry Acad, of Pharmaceutical Sciences, American Pharmaceutical Assn., New York, Raven Press.Google Scholar
  14. Guarino, A. M., Anderson, J. B., Starkweather, D. K., and Chignell, C. F., 1973, Cancer Chemotherapy Rep. 57: 125.Google Scholar
  15. Hart, L. G., and Fouts, J. R., 1965, Arch. Exp. Pathol Pharmacol. 249: 486.CrossRefGoogle Scholar
  16. Horak, V., and Gillette, J. R., 1971, Molecular Pharmacology 7: 429.PubMedGoogle Scholar
  17. Kalow, W., 1962, in: Symposium on Factors Controlling Duration of Action, Vol. 6, p. 137, (Brodie, B. B., and Erdos, E. G., eds.) Proceedings of the First International Pharmacology Meeting, Pergamon Press, New York.Google Scholar
  18. Kucera, J. L., and Bullock, F. J., 1969, J. Pharm. Pharmacol. 21: 293.PubMedCrossRefGoogle Scholar
  19. Kuntzman, R. Tsai, I., and Burns, J. J., 1962, J. Pharmacol. Exp. Therap. 158: 332.Google Scholar
  20. Lerman, L., 1961, J. Mol. Biol. 3: 18.PubMedCrossRefGoogle Scholar
  21. Potts, A. M., 1962, Invest. Ophthalmol. 1: 522.PubMedGoogle Scholar
  22. Riegelman, S., Loo, J., and Rowland, M., 1968, J. Pharm. Sci. 128: 123.Google Scholar
  23. Riggs, D. S., 1963, in: The Mathematical Approach to Physiological Problems, Williams and Wilkins, Baltimore, Md. 221–214.Google Scholar
  24. Robinson, J., Richardson, A., Hunter, C. G., Crabtree, A. N., and Rees, H. J., 1965, Brit. J. Ind. Med. 22: 220.Google Scholar
  25. Selby, S. M., 1970, in: Handbook of Tables for Mathematics, 4th ed., p. 14, (Selby, S. M., ed.) The Chemical Rubber Co., Cleveland, Ohio.Google Scholar
  26. Solomon, H. M., Schrogie, J. J., and Williams, D., 1968, Biochem. Pharmacol. 17: 143.PubMedCrossRefGoogle Scholar
  27. Spector, S., and Parker, C. W., 1970, Science 168: 1347.PubMedCrossRefGoogle Scholar
  28. Spector, S., 1971, J. Pharmacol. Exp. Therap. 178: 253.Google Scholar
  29. Waddell, W. J., and Butler, T. C., 1957, J. Clin. Invest. 36: 1217.PubMedCrossRefGoogle Scholar
  30. Waddell, W. J., and Butler, T. C., 1959, J. Clin. Invest. 38: 720.PubMedCrossRefGoogle Scholar
  31. Yesair, D. W., Remington, L., Callahan, M., and Kensler, C. J., 1970, Biochem. Pharmacol. 19: 1591.PubMedCrossRefGoogle Scholar
  32. Zweig, M. H., and Chignell, C. F., 1973, Biochem. Pharmacol, 22: 2141.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1972

Authors and Affiliations

  • James R. Gillette
    • 1
  1. 1.Laboratory of Chemical Pharmacology National Heart and Lung InstituteNational Institutes of HealthBethesdaUSA

Personalised recommendations